143 related articles for article (PubMed ID: 29305810)
1. Serum sickness with refractory nephrotic syndrome following treatment with rituximab.
Maeda R; Kawasaki Y; Ohara S; Suyama K; Hosoya M
CEN Case Rep; 2018 May; 7(1):69-72. PubMed ID: 29305810
[TBL] [Abstract][Full Text] [Related]
2. Rituximab-induced serum sickness in a 6-year-old boy with steroid-dependent nephrotic syndrome.
Nakamura M; Kanda S; Yoshioka Y; Takahashi C; Owada K; Kajiho Y; Harita Y; Oka A
CEN Case Rep; 2020 May; 9(2):173-176. PubMed ID: 31970629
[TBL] [Abstract][Full Text] [Related]
3. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T; Sako M; Nakanishi K; Ishikura K; Ito S; Nakamura H; Oba MS; Nozu K; Iijima K
BMC Nephrol; 2018 Nov; 19(1):302. PubMed ID: 30382824
[TBL] [Abstract][Full Text] [Related]
4. The case of Kawasaki disease after rituximab infusion triggered by human anti-chimeric antibodies.
Sato M; Yamada M; Nakajima M; Miyama Y; Kitayama H
CEN Case Rep; 2020 Nov; 9(4):392-394. PubMed ID: 32535844
[TBL] [Abstract][Full Text] [Related]
5. Rituximab-induced serum sickness in a girl with nephrotic syndrome.
Kimura Y; Kiyota K; Ikeuchi M; Sekiguchi K; Ihara K
CEN Case Rep; 2022 Nov; 11(4):506-510. PubMed ID: 35596114
[TBL] [Abstract][Full Text] [Related]
6. Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome.
Ito S; Kamei K; Ogura M; Udagawa T; Fujinaga S; Saito M; Sako M; Iijima K
Pediatr Nephrol; 2013 Feb; 28(2):257-64. PubMed ID: 23052656
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of rituximab therapy in children with refractory nephrotic syndrome: a prospective observational study in Shanghai.
Sun L; Xu H; Shen Q; Cao Q; Rao J; Liu HM; Fang XY; Zhou LJ
World J Pediatr; 2014 Feb; 10(1):59-63. PubMed ID: 24464665
[TBL] [Abstract][Full Text] [Related]
8. Rituximab-induced serum sickness and anaphylaxis in a child with nephrotic syndrome.
Bayram MT; Soylu A; Kavukçu S
Turk J Pediatr; 2020; 62(5):884-888. PubMed ID: 33108096
[TBL] [Abstract][Full Text] [Related]
9. Single Dose of Rituximab in Children with Steroid-Dependent / Frequently Relapsing Nephrotic Syndrome, Clinical Efficacy and Evaluation of Health-Related Quality of Life.
Wang L; Hua R; Zhu Y; Lu Y; Gao H; Xia X; Zhang Q; Lu L; Deng F
Iran J Kidney Dis; 2021 Mar; 1(2):109-115. PubMed ID: 33764321
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for relapse and long-term outcome in steroid-dependent nephrotic syndrome treated with rituximab.
Kamei K; Ogura M; Sato M; Sako M; Iijima K; Ito S
Pediatr Nephrol; 2016 Jan; 31(1):89-95. PubMed ID: 26341251
[TBL] [Abstract][Full Text] [Related]
11. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
[TBL] [Abstract][Full Text] [Related]
12. Rituximab for childhood refractory nephrotic syndrome.
Iijima K
Pediatr Int; 2011 Oct; 53(5):617-621. PubMed ID: 21771179
[TBL] [Abstract][Full Text] [Related]
13. Necrotizing Fasciitis: A Side Effect of Rituximab Administration in Steroid-Dependent Nephrotic Syndrome.
Safdar OY; Basunbul LI; Alhazmi LS; Almughamisi SA; Habib LA; Basaeed AJ; Kalaktawi NM; Alharithi ET; Aljaaly HA; Alzahrani WA
Int Med Case Rep J; 2022; 15():587-592. PubMed ID: 36281444
[TBL] [Abstract][Full Text] [Related]
14. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
Iijima K; Sako M; Nozu K; Mori R; Tuchida N; Kamei K; Miura K; Aya K; Nakanishi K; Ohtomo Y; Takahashi S; Tanaka R; Kaito H; Nakamura H; Ishikura K; Ito S; Ohashi Y;
Lancet; 2014 Oct; 384(9950):1273-81. PubMed ID: 24965823
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of rituximab for childhood refractory nephrotic syndrome: A meta-analysis of randomized controlled trials.
Chang D; Gong M; Liu C; Zhang Q; Hu Z; Li Z
Med Clin (Barc); 2021 Nov; 157(9):418-426. PubMed ID: 33070945
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of rituximab therapy against intractable steroid-resistant nephrotic syndrome.
Nakagawa T; Shiratori A; Kawaba Y; Kanda K; Tanaka R
Pediatr Int; 2016 Oct; 58(10):1003-1008. PubMed ID: 26865241
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of children with steroid-dependent nephrotic syndrome with rituximab].
Huang J; Du J; Wang S; Xiao L; Zhao X
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):521-4. PubMed ID: 25224058
[TBL] [Abstract][Full Text] [Related]
18. Late-onset adverse events after a single dose of rituximab in children with complicated steroid-dependent nephrotic syndrome.
Fujinaga S; Ozawa K; Sakuraya K; Yamada A; Shimizu T
Clin Nephrol; 2016 Jun; 85(6):340-5. PubMed ID: 27125626
[TBL] [Abstract][Full Text] [Related]
19. Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery.
Sellier-Leclerc AL; Baudouin V; Kwon T; Macher MA; Guérin V; Lapillonne H; Deschênes G; Ulinski T
Nephrol Dial Transplant; 2012 Mar; 27(3):1083-9. PubMed ID: 21810762
[TBL] [Abstract][Full Text] [Related]
20. Rituximab in children with steroid-dependent nephrotic syndrome: experience of a tertiary center and review of the literature.
Van Horebeek I; Knops N; Van Dyck M; Levtchenko E; Mekahli D
Acta Clin Belg; 2017 Jun; 72(3):147-155. PubMed ID: 27409338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
